Telix Pharmaceuticals Ltd — Major Shareholding Notification 2018

Sep 13, 2018

FORM 605 Corporations Act 2001 Section 671B

NOTICE OF CEASING TO BE A SUBSTANTIAL HOLDER

To: Company Name/Scheme TLX - Telix Pharmaceuticals Limited ACN/ARSN 616 620 369 1. Details of Substantial Holder(1) Name Acorn Capital Limited ACN/ARSN (if applicable) 082 694 531 There was a change in the interests of the 11/09/2018 substantial holder on The previous notice was given to the company on 17/11/2017 The previous notice was dated 17/11/2017 2. Changes in relevant interests Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:

Date of Change	Person whose relevant interest changed	Nature of change	Consideration given in relation to change	Class and number of securities affected	Person's votes affected
Ceasing due to Dilution

3. Changes in Associates

The persons who have become associates (2) of, ceased to be associates, or have change the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows:

Name and ACN/ARSN (if applicable) Name of Association

4. Addresses

The Addresses of persons named in this form are as follows:

Name	Address
Acorn Capital Limited	Level 12, 90 Collins Street Melbourne Vic 3000

Print Name PAUL PALUMBO Capacity Director Sign Here Date 14/09/2018

Page 1 of 2

Annexure A

This Annexure A referred to in the Form 605 Notice of Ceasing to be a Substantial Holder signed by me and dated 11/09/2018

==> picture [89 x 16] intentionally omitted <==

..................................................

PAUL PALUMBO Director

17-Nov-2017 to 11-Sep-2018

Date Of Change	Person whose relevant interest changed	Nature of Change	Consideration given in relation to change	Consideration given in relation to change	Consideration given in relation to change	Consideration given in relation to change	Person's votes affected
28/02/2018 15/06/2018 15/06/2018 29/06/2018	Acorn Capital Ltd Acorn Capital Ltd Acorn Capital Ltd Acorn Capital Ltd	Sale Sale Purchase Purchase		-$346,477.83 -$370,071.24 $221,762.34 $33,536.85		-675,000 ordinary shares -560,714 ordinary shares 334,899 ordinary shares 50,000 ordinary shares	-675,000 -560,714 334,899 50,000

Page 2 of 2